are glp 1 agonists safe MYTH BUSTER #1 “Weight-loss injections like GLP-1 medicines not safe.” Is this really true? GLP-1 receptor (such as Ozempic®) are among the most discussed anti-obesity medicines today. Unfortunately, misinformation on Exploring the Side Effects of

What is Retatrutide

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.

Read or listen now!

This drug, indicated for glycemic control in patients aged 10 years and above with type 2 diabetes, serves as an adjunct to diet and exercise

We used version 2 of the Cochrane risk-of-bias tool for randomised trials to assess risk of bias for the primary outcome

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.